Metallo-beta-lactamase-producing Pseudomonas Putida As a Reservoir of Multidrug Resistance Elements That Can Be Transferred to Successful Pseudomonas Aeruginosa Clones
Overview
Affiliations
Objectives: To study the prevalence, nature, involved genetic elements and epidemiology of metallo-beta-lactamase (MBL)-producing Pseudomonas aeruginosa and Pseudomonas putida isolated in a Spanish hospital between 2005 and 2008.
Methods: Etests were used for susceptibility testing and screening for MBLs, confirmed through bla(VIM) PCRs and sequencing. Clonal relatedness was evaluated by PFGE and multilocus sequence typing (MLST). MBL-carrying plasmids were characterized by restriction fragment length polymorphism, Southern blot and electroporation. MBL genetic elements were studied by cloning and sequencing.
Results: MBL-producing P. putida was detected in eight patients (one clone each; two harbouring bla(VIM-1) and six harbouring bla(VIM-2)), representing 14% of all the infections by the P. putida/fluorescens group. MBLs were detected in only 0.3% of P. aeruginosa infections (11 patients) during the same period. PFGE revealed four P. aeruginosa clones: one producing bla(VIM-13) (two patients); and three producing bla(VIM-2) (two patients, six patients and one patient, respectively). MLST indicated that the VIM-13 clone was the internationally spread sequence type (ST)235, while the major VIM-2 lineage corresponded to ST179, which is associated with chronic respiratory infections. The VIM-1 integron was shown to have both plasmid and chromosomal location, while the VIM-13 integron was only chromosomal. The VIM-2 integron was located in the same transposon (Tn402/Tn5053-like) in all P. aeruginosa and P. putida isolates, suggesting its crucial role in the dissemination of VIM-2.
Conclusions: The high diversity and proportion of MBL-positive P. putida suggests an environmental reservoir of these resistance determinants. Dissemination of these multidrug resistance elements to successful P. aeruginosa clones presents a major epidemiological and clinical threat.
Udaondo Z, Ramos J, Abram K FEMS Microbiol Rev. 2024; 48(6).
PMID: 39390673 PMC: 11585281. DOI: 10.1093/femsre/fuae025.
Three prolonged outbreaks of metallo-β-lactamase-producing in an Upper Austrian hospital, 2017-2023.
Cabal A, Hortenhuber A, Salaheddin Y, Stoger A, Springer B, Bletz S Microbiol Spectr. 2024; 12(10):e0074024.
PMID: 39162508 PMC: 11448029. DOI: 10.1128/spectrum.00740-24.
Integrons in the development of antimicrobial resistance: critical review and perspectives.
Bhat B, Mir R, Qadri H, Dhiman R, Almilaibary A, Alkhanani M Front Microbiol. 2023; 14:1231938.
PMID: 37720149 PMC: 10500605. DOI: 10.3389/fmicb.2023.1231938.
Maslova O, Beletsky A, Mindlin S, Petrova N, Mardanov A, Petrova M Int J Mol Sci. 2023; 24(17).
PMID: 37686323 PMC: 10488154. DOI: 10.3390/ijms241713518.
Li Q, Chen Q, Liang S, Wang W, Zhang B, Martin-Rodriguez A Front Cell Infect Microbiol. 2023; 13:1130333.
PMID: 36936768 PMC: 10015498. DOI: 10.3389/fcimb.2023.1130333.